Optoacoustic tomography (photoacoustic tomography) is an emerging imaging technology displaying great potential for medical diagnosis and preclinical research. Rationally designing activatable optoacoustic probes capable of diagnosing diseases and locating their foci can bring into full play the role of optoacoustic tomography (OAT) as a promising noninvasive imaging modality. Here we report two xanthene-based optoacoustic probes (C1X-OR1 and C2X-OR2) for temporospatial imaging of hepatic alkaline phosphatase (or β-galactosidase) for evaluating and locating drug-induced liver injury (or metastatic tumor). The probes rapidly respond to the disease-specific biomarkers by displaying red-shifted NIR absorption bands and generate prominent optoacoustic signals. Using multispectral optoacoustic tomography (MSOT), we can precisely localize the focus of drug-induced liver injury in mice using C1X-OR1, and the metastatic tumors using C2X-OR2. This work suggests that the activatable optoacoustic chromophores may potentially be applied for diagnosing and localizing disease foci, especially smaller and deeper ones.
An activatable nanoprobe for imaging breast cancer metastases through near infrared‐I (NIR‐I)/NIR‐II fluorescence imaging and multispectral optoacoustic tomography (MSOT) imaging was designed. With a dihydroxanthene moiety serving as the electron donor, quinolinium as the electron acceptor and nitrobenzyloxydiphenylamino as the recognition element, the probe can specifically respond to nitroreductase and transform into an activated D‐π‐A structure with a NIR emission band extending beyond 900 nm. The activated nanoprobe exhibits NIR emission enhanced by aggregation‐induced emission (AIE) and produces strong optoacoustic signal. The nanoprobe was used to detect and image metastases from the orthotopic breast tumors to lymph nodes and then to lung in two breast cancer mouse models. Moreover, the nanoprobe can monitor the treatment efficacy during chemotherapeutic course through fluorescence and MSOT imaging.
The precise location of tumor and
completeness of surgical resection
are critical to successful tumor surgery; thus, the method capable
of preoperatively locating a tumor site and intraoperatively determining
tumor margins would be highly ideal. Herein, an activatable nanocomposite
probe was developed for preoperatively locating orthotopic hepatic
tumor via multispectral optoacoustic tomography imaging and for intraoperative
navigation via near-IR-1 (NIR-I) and NIR-II fluorescence imaging.
The molecular probe comprises an electronic donor, an acceptor, and
a recognition moiety and forms the nanocomposite probe with bovine
serum albumin. The probe specifically responds to nitroreductase overexpressed
in tumor cells, which transforms the aromatic nitro group into an
electron-donating amino group and thus activates the probe. The activated
probe with the aggregation-induced emission feature generates strong
NIR-I/NIR-II fluorescence and optoacoustic signals for dual-mode imaging.
Owing to the in situ response toward nitroreductase in tumor cells
in the hepatic region, the probe is found capable of detecting early
stage orthotopic liver tumors. Furthermore, with the nanocomposite
probe, we can obtain the 3D MSOT images to accurately locate orthotopic
liver tumors preoperatively and the NIR-I/NIR-II fluorescence images
to provide intraoperative guidance for tumor resection surgery.
Metformin is currently the most prescribed oral agent for diabetes treatment; however the overdose or long-term use may cause some severe side effects such as liver injury. Researches indicate that metformin-induced liver injury is closely related to upregulation of hepatic H2S. Hence, monitoring hepatic H2S generation induced by metformin could be an effective approach for evaluating hepatoxicity of the drug.Methods: We present a novel turn-on and dual-mode probe for detecting and imaging metformin-induced liver injury by specifically tracking the upregulation of hepatic H2S with fluorescent and optoacoustic methods. After reaction with H2S, the strong electron-withdrawing group dinitrophenyl ether (which acts as both the recognition moiety and the fluorescence quencher) was cleaved and replaced by an electron-donating group hydroxyl. This correspondingly leads to the changes of the probe's electronic state and absorption red-shifting as well as the subsequent turn-on fluorescent and optoacoustic signals.Results: The probe was applied to the colon tumor-bearing mice model and the metformin-induced liver injury mice model to achieve tumor imaging and liver injury assessment. The biosafety of the probe was verified by histological analysis (hematoxylin and eosin staining) and serum biochemical assays.Conclusion: The probe responds quickly to H2S in tumors and the liver, and MSOT imaging with the probe offers cross-secitonal and 3D spatial information of liver injury. This study may provide an effective approach for accessing medication side effects by tracking drug-metabolism-related products.
Whilte herbal medicines are widely used for health promotion and therapy for chronic conditions, inappropriate use of them may cause adverse effects like liver injury, and accurately evaluating their hepatotoxicity is of great significance for public health. Herein, an activatable probe QY‐N for diagnosing herbal‐medicine‐induced liver injury by detecting hepatic NO with NIR‐II fluorescence and multispectral optoacoustic tomography (MSOT) imaging is demonstrated. The probe includes a bismethoxyphenyl‐amine‐containing dihydroxanthene serving as electron donor, a quinolinium as electron acceptor, and a butylamine as recognition group and fluorescence quencher. The hepatic level of NO reacts with butylamine, thereby generating the activated probe QY‐NO which exhibits a red‐shifted absorption band (700–850 nm) for optoacoustic imaging and generates strong emission (910–1110 nm) for NIR‐II fluorescence imaging. QY‐NO is aggregation‐induced‐emission (AIE) active, which ensures strong emission in aggregated state. QY‐N is utilized in the triptolide‐induced liver injury mouse model, and experimental results demonstrate the QY‐N can be activated by hepatic NO and thus be used in detecting herbal‐medicine‐induced liver injury. The temporal and spatial information provided by three‐dimensional MSOT images well delineates the site and size of liver injury. Moreover, QY‐N has also been employed to monitor rehabilitation of liver injury during treatment process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.